Geopolitical crises are taking a toll on stocks as we head into the seasonally weak month of August.
VIDEO ON MSN MONEY
The troubled financial institution is slowly crawling out of the hole it dug for itself.
According to Reuters, the Charlotte, N.C. company is considering unloading additional assets to comply with new capital rules. That's not surprising, given that the company has been selling everything -- $50 billion since 2010 -- that wasn't nailed down, including its stake in the largest Pizza Hut franchisee and the China Construction Bank.
Regulators "are trying to have us have more capital, more liquidity, so in a time of crisis, we can be there to support the economy and not have to shrink and retrench," CEO Brian Moynihan recently told the Boston Globe."We’re all for that."
The carrier clearly had the most to lose if the AT&T and T-Mobile merger had gone through.
Sprint welcomed AT&T's move as "the right decision" for customers, as the deal would have created "an undeniable duopoly that would have resulted in higher prices, less innovation and fewer choices for the American consumer." Sprint also lauded the Federal Communications Commission and the U.S. Department of Justice for a job well done.
Had the merger been approved, AT&T would have leapfrogged ahead of Verizon (VZ) as the largest wireless carrier in the U.S., leaving Sprint in an even more distant third place.
The giant e-tailer takes the long view with new shipping centers, aggressive pricing and growing customer base.
By Stephen Quickel,US Investment Report
Amazon.com (AMZN) is a controversial call that we think will bear rich fruit long-term, and should begin to perform nicely during 2012.
The giant Internet retailer, with revenues in the $50 billion range -- 10 times its sales in 2003 and twice its 2009 total -- has taken a great tumble.
Branded drugs are set to lose over $100 billion in revenue in the next few years, and Merck, like other large pharma companies, will need to develop new drugs to offset these losses.
Merck is the No. 2 pharmaceutical company in the world, offering prescription medicines, vaccines, biologic therapies, animal health and consumer care products. It delivered nearly $46 billion in revenue in 2010 with a profit of $861 million, or 28 cents a share. On a non-GAAP basis, earnings were $3.42 a share.
Merck competes with other pharmaceutical companies, including Pfizer (PFE), Abbott Labs (ABT), Johnson & Johnson (JNJ), Glaxo SmithKline (GSK) and Roche.
Regulators are investigating whether a recent infant death was related to the company's Enfamil product.
From fast food to salons and energy to tech, here are some ideas with great long-growth potential.
There is still potential for short-term market drops back toward the August lows, and until that probability is greatly reduced, it would be prudent to continue to hold a large cash reserve.
In the meantime, we continue to track numerous stocks with great growth potential; here, we present the current top prospects. If you do choose to invest in some of these, take care to buy on dips. And if you incur losses, keep them small, so you’ll still be in the game when the next big bull market gets rolling.
The new 4G device has impressive features, but competitors aren't standing still.
Mobile technology heading into 2012 is all about the marriage of two features: the lowest price tag and the highest specifications. Look no further than Apple's (AAPL) strategy with the recently released iPhone 4S. With a two-year contract at Verizon (VZ), AT&T (T) or Sprint (S), you can get a fine iPhone that sports a voice-operated personal assistant and an 8-megapixel camera that can shoot HD video in 1080p -- all for just $200. Some fancy specifications and a nice price.
Sony (SNE), true to tradition, is pushing at least the high-end aspect with its latest mobile devices.
Gogo aims to raise $100 million in an offering to help it expand operations.
The company is the main provider of on-board Wi-Fi in the U.S., and needs more money to expand its business. Gogo has filed paperwork to raise $100 million in an initial public offering, and will trade under the ticker symbol GOGO.
Gogo handles in-flight Internet for nine of the 10 North American airlines that offer the service, including Delta Air (DAL), Alaska Airlines (ALK), US Airways (LCC) and American Airlines, owned by AMR (AMR). It's on a trial basis with United Airlines (UAL).
The business uniform supplier blows past analyst estimates and raises 2012 guidance.
By Todd Bunton
Cintas (CTAS) delivered excellent second-quarter 2012 results Tuesday. Earnings per share came in at 57 cents, crushing the Zacks Consensus Estimate by 9 cents. It was a whopping 50% increase over the same quarter in 2011.
Revenue rose 9% to a record $1.02 billion, ahead of the Zacks Consensus Estimate of $1 billion. Organic revenue increased a solid 7% as the company maintained momentum in its rental uniforms and ancillary products segment, as well as in its first aid, safety and fire protection services segment. Operating income improved 30% year-over-year, while operating margin improved from 10.9% to 13%.
The video-streaming and DVD company is cutting the annual stock-option allowance for Reed Hastings.
The company has cut Hastings' annual stock-option allowance by half to $1.5 million, Bloomberg reports. A year ago, he was given $3 million in stock options.
Hastings didn't get a raise, either. His salary of $500,000 will stay the same.
Despite many challenges, Jamie Dimon's bank will be one of the winners on the new Wall Street.
Analyst Todd Hagerman of Sterne Agee hit the nail on the head when he identified headwinds that JPMorgan Chase (JPM) is going to face in the coming months. They range from the sluggish global economy to the new regulatory environment and other "structural changes that are affecting most of the bank’s core businesses."
And maybe Hagerman is right to suggest caution when it comes to loading up on the bank's stock -- on Wednesday he cut his rating on JPMorgan shares to "neutral" from "buy." Certainly, JPMorgan's much-lauded CEO Jamie Dimon appears to have a tin ear regarding the world beyond Wall Street, having dismissed the financial crisis as just another cyclical downturn and, more recently, shrugged off populist outrage at the behavior of behemoth banks.
Did management pass on possible acquisition talks?
There are plenty of ways it could have avoided its current quandary, starting by taking the advice of shareholders and employees instead of allowing co-CEOs Mike Lazaridis and Jim Balsillie to blindly charge ahead with their misaligned strategy. Reports are now surfacing that there could have been another outcome; it didn't have to be this way.
Ariad Pharmaceuticals, Monsanto and Accenture are a few names that could benefit if these events come to pass.
By Peter Leeds, guest columnist
The coming year will see major events play out, such as the presidential election, continued turmoil in Libya, and the potential fall of the euro. Each of these will create some key investment opportunities. Based on analysis I conduct for my financial newsletter, I'm expecting the following events to occur in 2012. I normally focus on penny stocks, but here I list some larger stocks I think will enjoy strong performances as a result of these events.
1. Obama will be re-elected
Based on percentages coming in from 9 battle ground states, and the number of electoral college votes from each, it appears that Obama would win if the election were held today. I expect his lead to increase as the campaign enters full swing.
The list includes names poised for capital appreciation over the next year.
A dynamic, actively managed portfolio, the S&P Top Ten Portfolio is comprised of stocks that S&P Equity Research believes to be well positioned for solid capital appreciation over the next 12 months.
Stocks must have our highest five-stars ranking to enter the portfolio. If the ranking drops below four stars, the stock will be removed.
In addition, any stock in the portfolio may be replaced with a five-star stock at any time.
Will the card giant be able to reinvent itself in 2012?
American Greetings (AM) shares plunged Thursday after the company said that third-quarter earnings fell almost 40% as sales and marketing costs rose. With those expenses eating into the bottom line, the company sharply cut its forecast for 2012.
Quarterly profit of 50 cents a share severely missed analyst estimates of 81 cents a share. The company further irritated investors by refusing to answer many analyst questions on its conference call, instead opting for "no comment" responses.
MORE ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
The company complains after the son of Florida State's football coach is televised wearing -- gasp -- Under Armour.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
[BRIEFING.COM] The stock market finished a down week on a cautious note with small caps leading the retreat. The Russell 2000 lost 0.5%, widening its weekly decline to 2.6%, while the S&P 500 shed 0.3%. The benchmark index ended the week lower by 2.7%.
This morning, the market was provided a basis to rebound with the July employment report, which was just right for the policy doves (209K versus Briefing.com consensus 220K). It showed payroll growth that was weaker than expected, ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|